Petra Diamonds Limited ( LON:PDL – Get Free Report )’s stock price was up 14.3% during mid-day trading on Friday . The company traded as high as GBX 32 ($0.40) and last traded at GBX 32 ($0.40). Approximately 765,189 shares changed hands during trading, an increase of 244% from the average daily volume of 222,309 shares. The stock had previously closed at GBX 28 ($0.35). Petra Diamonds Stock Up 13.6 % The company has a market capitalization of £61.76 million, a PE ratio of -96.36, a price-to-earnings-growth ratio of 0.17 and a beta of 1.45. The company’s fifty day moving average is GBX 32.39 and its 200-day moving average is GBX 32.77. The company has a debt-to-equity ratio of 140.09, a quick ratio of 3.52 and a current ratio of 1.32. About Petra Diamonds ( Get Free Report ) Petra Diamonds is a leading independent diamond mining group and a supplier of gem quality rough diamonds to the international market. The Company’s portfolio incorporates interests in three underground mines in South Africa (Cullinan Mine, Finsch and Koffiefontein) and one open pit mine in Tanzania (Williamson). Further Reading Receive News & Ratings for Petra Diamonds Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petra Diamonds and related companies with MarketBeat.com's FREE daily email newsletter .Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related conditions or take the drugs to become eligible for other services, health records and discussions with doctors show. An exclusive analysis of hundreds of thousands of electronic patient records by health data firm Truveta found slight, but measurable, increases in first-time diagnoses of sleep apnea, cardiovascular disease, and type 2 diabetes within 15 days of an initial prescription for a GLP-1 weight-loss drug between 2020 and 2024. In addition to obesity-related conditions, some patients are being prescribed the drugs to lose weight and become eligible for services, including organ transplants, fertility treatments or knee replacements, according to interviews with seven doctors and five other health experts. "This is a population that previously felt stigmatized by health care providers and often didn't return. But now that they're actually seeing themselves get healthier, asking clinicians questions and engaging more, I do think we're seeing new patients," said Dr. Rekha Kumar, a New York endocrinologist and obesity medicine specialist. Novo Nordisk's Wegovy and Ozempic and Eli Lilly's Zepbound and Mounjaro have been shown to lead to average weight loss of at least 15%. Andrew Friedson, director of health economics at the Milken Institute and three other experts said the impact of the drugs on overall healthcare use is not yet clear. The new diagnoses could mean higher initial spending, but early detection could save costs down the line, he said. Dr. Courtney Younglove, an obesity medicine specialist and founder of Heartland Weight Loss clinic in Overland Park, Kansas, said she has referred obesity patients for long-delayed pap smears and other routine care, including colonoscopies. Many overweight patients avoid doctors and routine tests for years due to the stigma and bias they often encounter, she said. “A lot of people with obesity don't do a lot of preventive health maintenance." Phil, a 43-year-old Chicago technology executive who asked for his full name to be withheld for privacy reasons, generally avoided doctors before receiving a GLP-1 prescription from a telehealth provider in early 2023. He said he told his regular physician about the medication months later, after he had lost more than 30 lbs, and was taken aback by her supportive response. He decided then to advocate more for himself and ask for help with other conditions, including addiction and mental health. "It gave me the courage to ask," he said. The Truveta analysis found that for every 1,000 patients with a first-time GLP-1 prescription, 42 were diagnosed with type 2 diabetes within 15 days in 2024, up from 32 in 2020. Over the same period, the number of sleep apnea diagnoses per 1,000 patients rose to 11 from 8 and the number of cardiovascular disease diagnoses increased to 15 from 13. The most obese patients were twice as likely as people who were less overweight to receive a type 2 diabetes diagnosis, and three times as likely to be diagnosed with sleep apnea, the Truveta data showed. The analysis was based on 33,630 first-time GLP-1 prescriptions for overweight or obese patients in 2020 and 224,496 in the first 10 months of 2024. Lilly declined to directly comment on the data, saying in an emailed statement "it is important that adults living with obesity receive appropriate diagnosis and access to evidence-based care." Novo Nordisk also declined to comment directly, noting its aim "to address unmet needs for a wider range of patients." QUALIFYING FOR SURGERIES ResMed, which sells sleep apnea devices, had revenue growth of 11% for its fiscal year ending in June - a trend the company attributed in part to the GLP-1 drugs. The medications are "bringing people into primary care like never before," ResMed CEO Michael Farrell said at the company's recent shareholder meeting. In addition to things like sleep apnea, the weight-loss drugs could lead to more joint replacements, said Sara Mallatt, director of healthcare research at market analysis firm AlphaSense. "As people's BMIs come down, they'll be eligible for surgeries they wouldn't otherwise," she said. "No one is saying this is happening in a meaningful way right now, but we think it will." University of Chicago Medicine last year launched a weight-loss clinic aimed at helping prospective organ transplant patients lose weight to qualify for surgery, with the GLP-1 drugs playing a key role. "Before they had a place to send these patients, which is our clinic, the scheduler would just say, 'hey, what's your weight, what's your height, what's your BMI,' and if they didn't fit their criteria, they would just tell them to lose weight on their own," said Anesia Reticker, the center's clinical pharmacist specialist. Retired Indiana steelworker Bensabio Guajardo, 68, was prescribed Ozempic at the clinic in 2023 when he was deemed too obese for a double lung transplant needed to keep him alive after pulmonary fibrosis made breathing increasingly difficult. "It helped me a lot. It took my cravings away," Guajardo said. After losing around 90 pounds and stopping the drug ahead of a successful surgery in May, his doctor put him back on it to control high blood sugar. Reticker said the program has received about 100 referrals over the past year from transplant centers in the Chicago area.
Applied Digital (NASDAQ:APLD) Trading Down 6.6% – Time to Sell?‘Authentic’ Jeremy Clarkson tops polls in disaffected, desperate UK
BERLIN (AP) — Tech entrepreneur Elon Musk caused uproar after backing Germany’s far-right party in a major newspaper ahead of key parliamentary elections in the Western European country, leading to the resignation of the paper’s opinion editor in protest. Germany is to vote in an early election on Feb. 23 after Chancellor Olaf Scholz’s three-party governing coalition collapsed last month in a dispute over how to revitalize the country’s stagnant economy. Musk's guest opinion piece for Welt am Sonntag —a sister publication of POLITICO owned by the Axel Springer Group — published in German over the weekend, was the second time this month he supported the Alternative for Germany, or AfD. “The Alternative for Germany (AfD) is the last spark of hope for this country," Musk wrote in his translated commentary. He went on to say the far-right party “can lead the country into a future where economic prosperity, cultural integrity and technological innovation are not just wishes, but reality.” The Tesla Motors CEO also wrote that his investment in Germany gave him the right to comment on the country's condition. The AfD is polling strongly, but its candidate for the top job, Alice Weidel , has no realistic chance of becoming chancellor because other parties refuse to work with the far-right party. An ally of U.S. President-elect Donald Trump, the technology billionaire challenged in his opinion piece the party's public image. “The portrayal of the AfD as right-wing extremist is clearly false, considering that Alice Weidel, the party’s leader, has a same-sex partner from Sri Lanka! Does that sound like Hitler to you? Please!” Musk’s commentary has led to a debate in German media over the boundaries of free speech, with the paper's own opinion editor announcing her resignation, pointedly on Musk's social media platform, X. “I always enjoyed leading the opinion section of WELT and WAMS. Today an article by Elon Musk appeared in Welt am Sonntag. I handed in my resignation yesterday after it went to print," Eva Marie Kogel wrote. A critical article by the future editor-in-chief of the Welt group, Jan Philipp Burgard, accompanied Musk’s opinion piece. “Musk’s diagnosis is correct, but his therapeutic approach, that only the AfD can save Germany, is fatally wrong,” Burgard wrote. Responding to a request for comment from the German Press Agency, dpa, the current editor-in-chief of the Welt group, Ulf Poschardt, and Burgard — who is due to take over on Jan. 1 — said in a joint statement that the discussion over Musk's piece was "very insightful. Democracy and journalism thrive on freedom of expression.” “This will continue to determine the compass of the “world” in the future. We will develop “Die Welt” even more decisively as a forum for such debates,” they wrote to dpa.Contra Costa County adopts gender-neutral pronouns as movement grows in Bay Area
NoneIndiana Jones, Hellblade 2 and Star Wars Outlaws compete for DF's 'best graphics of the year' awardFederal regulators announced plans to further evaluate the safety of vehicles equipped with automated driving systems, a potential precursor to nationwide standards for rapidly advancing self-driving technology. The ADS-equipped Vehicle Safety, Transparency, and Evaluation Program, known as AV STEP, would create a voluntary review and reporting framework for companies with ADS-equipped vehicles on public roads. “AV STEP would provide a valuable national framework at a pivotal time in the development of ADS technology. Safe, transparent, and responsible development is critical for this technology to be trusted by the public and reach its full potential,” said Adam Raviv, chief counsel for the National Highway Traffic Safety Administration. The fate of the program, however, is unclear with Tesla Inc. CEO Elon Musk appearing to play a big role in shaping the priorities of President-elect Donald Trump. Musk has called for national ADS standards to replace the patchwork of state policies across the country. But the billionaire tech mogul, according to Reuters, has also called for an end to existing crash reporting rules that he claims unfairly represent Tesla’s safety record. Tesla is an industry leader in ADS technology with the Autopilot and “Full Self Driving” features already available in its vehicles, but legacy automakers have invested significantly in developing their own systems. Each of the Detroit Three automakers — Ford Motor Co., General Motors Co. and Stellantis NV — has an ADS system that is either available now or coming soon to new vehicles. Under current regulations, NHTSA explained in its Friday regulatory filing, motor vehicle manufacturers may already deploy ADS-equipped vehicles on public roads, as long as they comply with existing Federal Motor Vehicle Safety Standards (FMVSS) and state and local laws. The agency has called for “everyone” to submit comments on the 265-page program proposal. The Alliance for Automotive Innovation, a top lobbying group representing all major automakers except for Tesla, praised the proposal. “We’ve been critical of regulators for standing still on AVs. Why? Because we urgently need a regulatory framework for AVs in the U.S., so we don’t cede leadership to China and other countries,” said John Bozzella, the group’s president and CEO. “AV STEP is a positive step forward and a pathway to ramp up the number of AVs operating on the roads under the oversight of the country’s primary vehicle safety regulator,” he added. Cathy Chase, president of Advocates for Highway and Auto Safety, was less supportive of the proposal. “Expanding the deployment of ADS — and without the safety protections provided by FMVSSs — at this time seems premature and lacks independent research and data to support the action,” she said. “This (proposal) ignores the havoc created by vehicles with ADS already on the roads and opens the floodgates for more of them with even fewer safety protections,” she added. “The promise of data collection should not come at the peril of all road users.” Instead, Chase said, “NHTSA should be bringing requirements for congressionally-mandated, proven safety systems over the finish line, including AEB for commercial motor vehicles, impaired driving prevention systems and detection and alert systems to prevent pediatric heatstroke.” Advocates for self-driving technology have hailed it as a revolutionary breakthrough that could slash the number of road deaths in the United States, which usually exceeds 40,000 each year, but high-profile crashes involving ADS have fueled some public skepticism. Originally published in the Detroit News.
Green Bay Packers quarterback Jordan Love played interception-free football for the first time this season during a home rout of the San Francisco 49ers on Sunday. The Packers' Thanksgiving night home clash with the Miami Dolphins offers a chance to be equally efficient. Just don't expect Love to scale back his approach in the meeting of playoff contenders. ADVERTISEMENT "I definitely am a guy who always wants those big plays, want to put that pressure on the defense and take some of those shots," Love said. Love threw for a season-low 163 yards on 13-of-23 passing to go with two touchdowns against the 49ers. Still, with Josh Jacobs (26 carries, 106 yards, three touchdowns) wreaking havoc in the running game, Love found opportunities to strike a balance. "Those are the lessons that I had to learn last year and I'll continue to learn: just when the right time (is) to take those shots," he said. "If guys get a step or we're in the right coverage versus just finding those completions. Because these check-downs and just finding those completions turn into big plays, as well, sometimes." Green Bay (8-3) is third in the rugged NFC North but holds a two-game lead in the loss column for the No. 6 seed in the conference playoff race. Winners of three straight, the Dolphins (5-6) are 1 1/2 games behind the Denver Broncos for the seventh seed in the AFC. "I think this is an awesome opportunity," Dolphins quarterback Tua Tagovailoa said. "Being able to play Thursday night football, prime time on Thanksgiving." Tagovailoa continues to surge since returning from injured reserve in Week 8. With four touchdown passes during a 34-15 home win against the New England Patriots on Sunday, he has 11 TDs through the air against just one interception in his five games back. ADVERTISEMENT Tagovailoa dismissed the notion that chilly temperatures in Green Bay on Thursday could be enough to cool him. The Hawaiian-born signal-caller is 0-7 when the temperature is 40 degrees or lower. "To me, it's just a mindset," he said. "That's really all there is." Added Miami defensive coordinator Anthony Weaver: "I've never lost a game and thought, 'Guys, it was too cold outside.'" Miami boasts a versatile set of playmakers for Green Bay to defend. Running back De'Von Achane also is active in the passing game, as he made two touchdown receptions against New England. Among the Dolphins' receivers, wideouts Tyreek Hill and Jaylen Waddle and tight end Jonnu Smith each have at least 41 receptions and 535 yards. The three have combined for nine TDs. Green Bay is hoping for another jolt from second-year linebacker Lukas Van Ness, whose strip-sack against the 49ers was the big play he said he needed for his confidence. It led to Jacobs' third TD. "I told myself I'm going to get off the ball, use my God-given abilities and just get in the backfield and make a play," Van Ness said. "So I think that's what I've wanted to do all year. I just need to continue that." ADVERTISEMENT The Dolphins said Wednesday that Hill, who has dealt with wrist and personal issues this week, does not have an injury designation and will play against the Packers. Cornerback Kendall Fuller (concussion) and linebackers Tyus Bowser (knee/calf) and Anthony Walker Jr. (hamstring) have been ruled out, and offensive tackle Terron Armstead (knee) is questionable. The Packers ruled out wide receiver Romeo Doubs (concussion), cornerback Jaire Alexander (knee) and linebacker Edgerrin Cooper (hamstring) after they did not practice all week. Tight end John FitzPatrick (back), linebacker Isaiah McDuffie (ankle) and offensive lineman Josh Myers (pectoral) were listed as questionable. Miami leads the all-time series 10-6, but Green Bay has won five of the past six matchups. The teams' most recent meeting also came on a holiday, with the visiting Packers prevailing 26-20 on Christmas Day 2022. Green Bay won each of its previous November home games against Miami, in 2002 and 2018. ______________________________________________________ This story was written by one of our partner news agencies. Forum Communications Company uses content from agencies such as Reuters, Kaiser Health News, Tribune News Service and others to provide a wider range of news to our readers. Learn more about the news services FCC uses here .
Jimmy Carter, the 39th president and a Nobel Peace Prize recipient, has died at 100
Dunn with 28 and Carnegie with 24 highlight No. 13 Georgia Tech women's 100-61 rout of Pittsburgh
Noni Madueke has no doubts that Chelsea ’s young squad would be “up for” a Premier League title race - but insists they are not getting distracted by thoughts of reeling in Liverpool just yet. Both Enzo Maresca and his players have been steadfast in insisting it is too soon for the Blues to challenge for the title, despite their superb start to the season. Maresca’s side are the division’s top-scorers and climbed to second after hammering Southampton 5-1 on Wednesday night. That result, coupled with Liverpool’s thrilling 3-3 draw at Newcastle has seen the gap to the runaway leaders close to seven points heading into the busy festive period and Maresca’s charges appear to be building strong momentum at just the right time. Madueke, however, says all focus is on themselves, and not catching Arne Slot’s men. “Of course we are up for it,” Madueke said when asked about the title race. “[But] whether we are in it or not is a different question. “However, we are taking every game as it comes. We are trying to progress and trying to get better. We are focusing on ourselves, really, and really trying to improve. “We won 5-1 [at Southampton] and in the dressing room we are very happy with that, but we also know that we can be a lot better. It’s really focusing on us, focusing on training and trying to improve.” Madueke scored one and set-up another in the thrashing of the Saints, on his return to the lineup after being left out of Sunday’s win over Aston Villa. Maresca revealed that he had taken the decision to axe Madueke for that game after growing frustrated at the winger’s performances in training , and urged him to be “more ambitious”. Still, the Italian insisted he is pleased with the 22-year-old’s progress this season and Madueke himself praised the manager’s tough love approach. “He is honest and truthful,” he added. “He tells the truth and he is a man you can trust. That’s all you want from a coach. “He is not necessarily a coach that is trying to be best friends with everyone, but he is a coach that is straight with everyone and fair to everyone. That’s what you need at a top club like Chelsea.”Jimmy Carter, the 39th president and a Nobel Peace Prize recipient, has died at 100
Vikings make myriad of roster moves to ensure special teams don't crater amid injury issuesThis rumor is popping up everywhere online and it’s driving people absolutely crazy. Everyone’s asking the same question: Will New Jersey ever get its first In-N-Out ? The hype is real, and you’ve probably seen a lot about where the chain restaurant will expand in the future all over social media. It’s the kind of news that’s got people buzzing because who wouldn’t want a bite of that famous burger right in their backyard? What is In-N-Out Burger? For anyone who doesn’t know, In-N-Out is a super popular fast-food chain known for its fresh burgers and secret menu. They started on the West Coast and have a huge following there. They’re all about simple yet amazing fast food. There are a very limited amount of menu items, but they do every single thing on that menu amazingly. READ MORE: Can You Keep Chickens in Your Pennsylvania Backyard? People on the East Coast, including plenty of New Jersey residents, have been begging for years to get a location closer to home. Right now, if anyone in Jersey wants to try it, they’ve got to jump on a plane or take a long road trip which isn't fair! Will In-N-Out Burger Come to New Jersey? So, what’s the deal? Will we ever see that legendary In-N-Out sign somewhere in the Garden State? While In-N-Out doesn’t have any set plans to open in New Jersey right now, they are expanding to Nashville, Tennessee, in 2026 according to Yahoo . That’s the furthest East they’ve ever gone so far. It might not be Jersey yet, but it’s a huge step in the right direction. That’s definitely good news for anyone holding out hope it will come to us in The Garden State. Who knows, maybe New Jersey could be next. Until then, we’ll just have to keep dreaming and scrolling through all those amazing Flying Dutchman and Double Double videos oon TikTok for the time being. Celebrities Eating In-N-Out Burger Pennsylvania's 15 Best Public Schools - RANKED Niche has listed the best public schools across Pennsylvania and this is the top 15! Gallery Credit: GiannaCHARLOTTE, N.C. (AP) — Quimari Peterson had 16 points in East Tennessee State's 75-55 win over Charlotte on Wednesday. Peterson had five rebounds for the Buccaneers (5-2). John Buggs III went 6 of 12 from the field (3 for 5 from 3-point range) to add 15 points. Karon Boyd shot 3 for 8 (1 for 3 from 3-point range) and 7 of 10 from the free-throw line to finish with 14 points, while adding seven rebounds. Jaehshon Thomas led the way for the 49ers (3-3) with 13 points. Charlotte also got 13 points from Nik Graves. ___ The Associated Press created this story using technology provided by and data from . The Associated Press
Colorado political, civic leaders react to passing of former President Carter
Lument Finance Trust, Inc. (LFT) to Issue Quarterly Dividend of $0.09 on January 15thHow to Watch Top 25 Women’s College Basketball Games – Thursday, November 28